Cell and Gene Therapy Day
New York CityReporting on the Latest Cell & Gene Therapy Progress for Cancer Immunotherapy
Reporting on the Latest Cell & Gene Therapy Progress for Cancer Immunotherapy
Designed by lead Advisors Dr Axel Hoos (GSK) and Dr James Gulley (NCI), the program provided a unique 360-degree approach addressing the business aspects, clinical advancements and scientific data to help accelerate clinical trials and FDA approval.